Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The decision is based on the phase 3 DESTINY-Breast11 trial
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
Subscribe To Our Newsletter & Stay Updated
